EU Indices slightly down this morning | TA focus on Vivendi

European stocks report 20 April 2020: Polymetal | EssilorLuxottica | Vivendi | Philips...

Trading floor 3

INDICES
Friday, European stocks rebounded further, with the Stoxx Europe 600 Index gaining 2.6%. Germany's DAX 30 climbed 3.2%, the U.K.'s FTSE 100 increased 2.8%. and France's CAC 40 jumped 3.4%.

EUROPE ADVANCE/DECLINE
90% of STOXX 600 constituents traded higher Friday.
85% of the shares trade above their 20D MA vs 74% Thursday (above the 20D moving average).
20% of the shares trade above their 200D MA vs 17% Thursday (above the 20D moving average).

The Euro Stoxx 50 Volatility index eased 2.06pts to 41.2, a new 52w high.

SECTORS vs STOXX 600
3mths relative high: none
3mths relative low: Real Estate

Europe Best 3 sectors
travel & leisure, automobiles & parts, industrial goods & services

Europe worst 3 sectors
utilities, telecommunications, health care

INTEREST RATE
The 10yr Bund yield fell 1bp to -0.47% (below its 20D MA). The 2yr-10yr yield spread fell 0bp to -21bps (above its 20D MA).

ECONOMIC DATA
GE 07:00: Mar PPI YoY, exp.: -0.1%
GE 07:00: Mar PPI MoM, exp.: -0.4%
EC 09:00: Feb Current Account, exp.: E8.7B
EC 10:00: Feb Balance of Trade, exp.: E1.3B
FR 14:00: 6-Mth BTF auction, exp.: -0.45%
FR 14:00: 3-Mth BTF auction, exp.: -0.48%
FR 14:00: 12-Mth BTF auction, exp.: -0.43%

MORNING TRADING
In Asian trading hours, EUR/USD edged down to 1.0865 and GBP/USD dropped to 1.2483. USD/JPY bounced to 107.80. This morning, official data showed that Japan's exports declined 11.7% on year in March (-9.4% estimated). NZD/USD eased to 0.6015. Earlier today, official data showed that New Zealand's CPI grew 2.5% on year in the first quarter (+2.1% expected).

Spot gold remained subdued at $1,680 an ounce.


#UK - IRELAND#
Polymetal, a precious metals mining company, posted a 1Q production report: "The Company's Q1 gold equivalent (GE) production grew by 5% y-o-y to 391 Koz. (...) Quarterly revenue increased by 9% y-o-y to US$ 494 million on the back of higher gold prices. Sales volumes decreased by 7% y-o-y due to the COVID-related slowdown of concentrate shipments to China, which have fully normalised since early March. (...) The Company confirms its 2020 production guidance of 1.6 Moz of GE."

Plus500, an online service provider for trading Contracts for Difference, announced that CEO Asaf Elimelech has decided to step down from his position, while COO David Zruia will assume the role of interim CEO with immediate effect.

Diageo, an alcoholic beverages company, was downgraded to "equalweight" from "overweight" at Morgan Stanley. 

Prudential, an insurance group, was downgraded to "hold" from "buy" at HSBC.


#FRANCE#
EssilorLuxottica, an eyecare conglomerate, announced that it has decided to not propose a dividend distribution for 2019, saying: "If the recovery is solid enough, the Board of Directors may propose a special dividend payment before the end of 2020."

Vivendi, a mass media conglomerate, announced that 1Q revenue increased 11.8% on year (+4.4% organic growth) to 3.87 billion euros. The company said the coronavirus pandemic had a limited impact in 1Q, though 2Q results are expected to be affected by the current health crisis.


Source: GAIN Capital, TradingView

Total, an oil giant, was downgraded to "equalweight" from "overweight" at Morgan Stanley.


#BENELUX#
Philips, a health technology company, announced that 1Q net income slumped to 30 million euros from 162 million euros in the prior-year period and adjusted EBITDA dropped 14% on year to 495 million euros on revenue of 4.16 billion euros, broadly flat (-2% on a comparable basis). The company stated: "For the full year 2020 we aim to achieve a modest comparable sales growth and Adjusted EBITA margin improvement. Given the current uncertainty and volatility, we will not provide more specific guidance for 2020 at this time."


#SWITZERLAND#
Novartis, a pharmaceutical group, said it has reached an agreement with the U.S. Food and Drug Administration to proceed with a phase 3 clinical trial to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. Meanwhile, the company announced the acquisition of Amblyotech, an U.S. software startup, for an undisclosed fee.


EX-DIVIDEND
Airbus Group: E1.8, Ferrari: E1.13, UniCredit: E0.63

More from Equities

Related Articles

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.